The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmacovigilance Services Market Research Report 2025

Global Pharmacovigilance Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1723714

No of Pages : 107

Ask Your Query

Report Description
Table of Content

Synopsis
The global Pharmacovigilance Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance Services.
Report Scope
The Pharmacovigilance Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacovigilance Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PrimeVigilance
Quanticate
ProPharma
Parexel
Accenture
SOTERIUS
SGS
Medpace
PPD
QVigilance
Freyr Solutions
Navitas Life Sciences
MMS Holdings
Amarex
Astrix Technology Group
Cambridge Regulatory Services
CROMSOURCE
APCER Life Sciences
Pharmya
A+Science
Midas Pharma
George Clinical
Syneos Health
INPHARMATIS
Taimei Technology
Extedo
WCG Clinical
Segment by Type
Adverse Event Case Management
Aggregate Reporting
Signal Intelligence
Risk Management
Segment by Application
Biotechnology and Pharmaceuticals
Contract Research Organization
Hospital
KPO / BPO
Healthcare Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Adverse Event Case Management
1.2.3 Aggregate Reporting
1.2.4 Signal Intelligence
1.2.5 Risk Management
1.3 Market by Application
1.3.1 Global Pharmacovigilance Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance Services Market Perspective (2019-2030)
2.2 Pharmacovigilance Services Growth Trends by Region
2.2.1 Global Pharmacovigilance Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance Services Market Dynamics
2.3.1 Pharmacovigilance Services Industry Trends
2.3.2 Pharmacovigilance Services Market Drivers
2.3.3 Pharmacovigilance Services Market Challenges
2.3.4 Pharmacovigilance Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Services Players by Revenue
3.1.1 Global Top Pharmacovigilance Services Players by Revenue (2019-2024)
3.1.2 Global Pharmacovigilance Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance Services Revenue
3.4 Global Pharmacovigilance Services Market Concentration Ratio
3.4.1 Global Pharmacovigilance Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Services Revenue in 2023
3.5 Pharmacovigilance Services Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance Services Product Solution and Service
3.7 Date of Enter into Pharmacovigilance Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance Services Breakdown Data by Type
4.1 Global Pharmacovigilance Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance Services Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance Services Breakdown Data by Application
5.1 Global Pharmacovigilance Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance Services Market Size (2019-2030)
6.2 North America Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacovigilance Services Market Size by Country (2019-2024)
6.4 North America Pharmacovigilance Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacovigilance Services Market Size (2019-2030)
7.2 Europe Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacovigilance Services Market Size by Country (2019-2024)
7.4 Europe Pharmacovigilance Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmacovigilance Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacovigilance Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacovigilance Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacovigilance Services Market Size (2019-2030)
9.2 Latin America Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacovigilance Services Market Size by Country (2019-2024)
9.4 Latin America Pharmacovigilance Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmacovigilance Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacovigilance Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacovigilance Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PrimeVigilance
11.1.1 PrimeVigilance Company Detail
11.1.2 PrimeVigilance Business Overview
11.1.3 PrimeVigilance Pharmacovigilance Services Introduction
11.1.4 PrimeVigilance Revenue in Pharmacovigilance Services Business (2019-2024)
11.1.5 PrimeVigilance Recent Development
11.2 Quanticate
11.2.1 Quanticate Company Detail
11.2.2 Quanticate Business Overview
11.2.3 Quanticate Pharmacovigilance Services Introduction
11.2.4 Quanticate Revenue in Pharmacovigilance Services Business (2019-2024)
11.2.5 Quanticate Recent Development
11.3 ProPharma
11.3.1 ProPharma Company Detail
11.3.2 ProPharma Business Overview
11.3.3 ProPharma Pharmacovigilance Services Introduction
11.3.4 ProPharma Revenue in Pharmacovigilance Services Business (2019-2024)
11.3.5 ProPharma Recent Development
11.4 Parexel
11.4.1 Parexel Company Detail
11.4.2 Parexel Business Overview
11.4.3 Parexel Pharmacovigilance Services Introduction
11.4.4 Parexel Revenue in Pharmacovigilance Services Business (2019-2024)
11.4.5 Parexel Recent Development
11.5 Accenture
11.5.1 Accenture Company Detail
11.5.2 Accenture Business Overview
11.5.3 Accenture Pharmacovigilance Services Introduction
11.5.4 Accenture Revenue in Pharmacovigilance Services Business (2019-2024)
11.5.5 Accenture Recent Development
11.6 SOTERIUS
11.6.1 SOTERIUS Company Detail
11.6.2 SOTERIUS Business Overview
11.6.3 SOTERIUS Pharmacovigilance Services Introduction
11.6.4 SOTERIUS Revenue in Pharmacovigilance Services Business (2019-2024)
11.6.5 SOTERIUS Recent Development
11.7 SGS
11.7.1 SGS Company Detail
11.7.2 SGS Business Overview
11.7.3 SGS Pharmacovigilance Services Introduction
11.7.4 SGS Revenue in Pharmacovigilance Services Business (2019-2024)
11.7.5 SGS Recent Development
11.8 Medpace
11.8.1 Medpace Company Detail
11.8.2 Medpace Business Overview
11.8.3 Medpace Pharmacovigilance Services Introduction
11.8.4 Medpace Revenue in Pharmacovigilance Services Business (2019-2024)
11.8.5 Medpace Recent Development
11.9 PPD
11.9.1 PPD Company Detail
11.9.2 PPD Business Overview
11.9.3 PPD Pharmacovigilance Services Introduction
11.9.4 PPD Revenue in Pharmacovigilance Services Business (2019-2024)
11.9.5 PPD Recent Development
11.10 QVigilance
11.10.1 QVigilance Company Detail
11.10.2 QVigilance Business Overview
11.10.3 QVigilance Pharmacovigilance Services Introduction
11.10.4 QVigilance Revenue in Pharmacovigilance Services Business (2019-2024)
11.10.5 QVigilance Recent Development
11.11 Freyr Solutions
11.11.1 Freyr Solutions Company Detail
11.11.2 Freyr Solutions Business Overview
11.11.3 Freyr Solutions Pharmacovigilance Services Introduction
11.11.4 Freyr Solutions Revenue in Pharmacovigilance Services Business (2019-2024)
11.11.5 Freyr Solutions Recent Development
11.12 Navitas Life Sciences
11.12.1 Navitas Life Sciences Company Detail
11.12.2 Navitas Life Sciences Business Overview
11.12.3 Navitas Life Sciences Pharmacovigilance Services Introduction
11.12.4 Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2019-2024)
11.12.5 Navitas Life Sciences Recent Development
11.13 MMS Holdings
11.13.1 MMS Holdings Company Detail
11.13.2 MMS Holdings Business Overview
11.13.3 MMS Holdings Pharmacovigilance Services Introduction
11.13.4 MMS Holdings Revenue in Pharmacovigilance Services Business (2019-2024)
11.13.5 MMS Holdings Recent Development
11.14 Amarex
11.14.1 Amarex Company Detail
11.14.2 Amarex Business Overview
11.14.3 Amarex Pharmacovigilance Services Introduction
11.14.4 Amarex Revenue in Pharmacovigilance Services Business (2019-2024)
11.14.5 Amarex Recent Development
11.15 Astrix Technology Group
11.15.1 Astrix Technology Group Company Detail
11.15.2 Astrix Technology Group Business Overview
11.15.3 Astrix Technology Group Pharmacovigilance Services Introduction
11.15.4 Astrix Technology Group Revenue in Pharmacovigilance Services Business (2019-2024)
11.15.5 Astrix Technology Group Recent Development
11.16 Cambridge Regulatory Services
11.16.1 Cambridge Regulatory Services Company Detail
11.16.2 Cambridge Regulatory Services Business Overview
11.16.3 Cambridge Regulatory Services Pharmacovigilance Services Introduction
11.16.4 Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2019-2024)
11.16.5 Cambridge Regulatory Services Recent Development
11.17 CROMSOURCE
11.17.1 CROMSOURCE Company Detail
11.17.2 CROMSOURCE Business Overview
11.17.3 CROMSOURCE Pharmacovigilance Services Introduction
11.17.4 CROMSOURCE Revenue in Pharmacovigilance Services Business (2019-2024)
11.17.5 CROMSOURCE Recent Development
11.18 APCER Life Sciences
11.18.1 APCER Life Sciences Company Detail
11.18.2 APCER Life Sciences Business Overview
11.18.3 APCER Life Sciences Pharmacovigilance Services Introduction
11.18.4 APCER Life Sciences Revenue in Pharmacovigilance Services Business (2019-2024)
11.18.5 APCER Life Sciences Recent Development
11.19 Pharmya
11.19.1 Pharmya Company Detail
11.19.2 Pharmya Business Overview
11.19.3 Pharmya Pharmacovigilance Services Introduction
11.19.4 Pharmya Revenue in Pharmacovigilance Services Business (2019-2024)
11.19.5 Pharmya Recent Development
11.20 A+Science
11.20.1 A+Science Company Detail
11.20.2 A+Science Business Overview
11.20.3 A+Science Pharmacovigilance Services Introduction
11.20.4 A+Science Revenue in Pharmacovigilance Services Business (2019-2024)
11.20.5 A+Science Recent Development
11.21 Midas Pharma
11.21.1 Midas Pharma Company Detail
11.21.2 Midas Pharma Business Overview
11.21.3 Midas Pharma Pharmacovigilance Services Introduction
11.21.4 Midas Pharma Revenue in Pharmacovigilance Services Business (2019-2024)
11.21.5 Midas Pharma Recent Development
11.22 George Clinical
11.22.1 George Clinical Company Detail
11.22.2 George Clinical Business Overview
11.22.3 George Clinical Pharmacovigilance Services Introduction
11.22.4 George Clinical Revenue in Pharmacovigilance Services Business (2019-2024)
11.22.5 George Clinical Recent Development
11.23 Syneos Health
11.23.1 Syneos Health Company Detail
11.23.2 Syneos Health Business Overview
11.23.3 Syneos Health Pharmacovigilance Services Introduction
11.23.4 Syneos Health Revenue in Pharmacovigilance Services Business (2019-2024)
11.23.5 Syneos Health Recent Development
11.24 INPHARMATIS
11.24.1 INPHARMATIS Company Detail
11.24.2 INPHARMATIS Business Overview
11.24.3 INPHARMATIS Pharmacovigilance Services Introduction
11.24.4 INPHARMATIS Revenue in Pharmacovigilance Services Business (2019-2024)
11.24.5 INPHARMATIS Recent Development
11.25 Taimei Technology
11.25.1 Taimei Technology Company Detail
11.25.2 Taimei Technology Business Overview
11.25.3 Taimei Technology Pharmacovigilance Services Introduction
11.25.4 Taimei Technology Revenue in Pharmacovigilance Services Business (2019-2024)
11.25.5 Taimei Technology Recent Development
11.26 Extedo
11.26.1 Extedo Company Detail
11.26.2 Extedo Business Overview
11.26.3 Extedo Pharmacovigilance Services Introduction
11.26.4 Extedo Revenue in Pharmacovigilance Services Business (2019-2024)
11.26.5 Extedo Recent Development
11.27 WCG Clinical
11.27.1 WCG Clinical Company Detail
11.27.2 WCG Clinical Business Overview
11.27.3 WCG Clinical Pharmacovigilance Services Introduction
11.27.4 WCG Clinical Revenue in Pharmacovigilance Services Business (2019-2024)
11.27.5 WCG Clinical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pharmacovigilance Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Adverse Event Case Management
Table 3. Key Players of Aggregate Reporting
Table 4. Key Players of Signal Intelligence
Table 5. Key Players of Risk Management
Table 6. Global Pharmacovigilance Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharmacovigilance Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pharmacovigilance Services Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Pharmacovigilance Services Market Share by Region (2019-2024)
Table 10. Global Pharmacovigilance Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Pharmacovigilance Services Market Share by Region (2025-2030)
Table 12. Pharmacovigilance Services Market Trends
Table 13. Pharmacovigilance Services Market Drivers
Table 14. Pharmacovigilance Services Market Challenges
Table 15. Pharmacovigilance Services Market Restraints
Table 16. Global Pharmacovigilance Services Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Pharmacovigilance Services Market Share by Players (2019-2024)
Table 18. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2023)
Table 19. Ranking of Global Top Pharmacovigilance Services Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Pharmacovigilance Services Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmacovigilance Services Product Solution and Service
Table 23. Date of Enter into Pharmacovigilance Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacovigilance Services Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Pharmacovigilance Services Revenue Market Share by Type (2019-2024)
Table 27. Global Pharmacovigilance Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Pharmacovigilance Services Revenue Market Share by Type (2025-2030)
Table 29. Global Pharmacovigilance Services Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Pharmacovigilance Services Revenue Market Share by Application (2019-2024)
Table 31. Global Pharmacovigilance Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Pharmacovigilance Services Revenue Market Share by Application (2025-2030)
Table 33. North America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Pharmacovigilance Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Pharmacovigilance Services Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Pharmacovigilance Services Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pharmacovigilance Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Pharmacovigilance Services Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Pharmacovigilance Services Market Size by Country (2025-2030) & (US$ Million)
Table 48. PrimeVigilance Company Detail
Table 49. PrimeVigilance Business Overview
Table 50. PrimeVigilance Pharmacovigilance Services Product
Table 51. PrimeVigilance Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 52. PrimeVigilance Recent Development
Table 53. Quanticate Company Detail
Table 54. Quanticate Business Overview
Table 55. Quanticate Pharmacovigilance Services Product
Table 56. Quanticate Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 57. Quanticate Recent Development
Table 58. ProPharma Company Detail
Table 59. ProPharma Business Overview
Table 60. ProPharma Pharmacovigilance Services Product
Table 61. ProPharma Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 62. ProPharma Recent Development
Table 63. Parexel Company Detail
Table 64. Parexel Business Overview
Table 65. Parexel Pharmacovigilance Services Product
Table 66. Parexel Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 67. Parexel Recent Development
Table 68. Accenture Company Detail
Table 69. Accenture Business Overview
Table 70. Accenture Pharmacovigilance Services Product
Table 71. Accenture Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 72. Accenture Recent Development
Table 73. SOTERIUS Company Detail
Table 74. SOTERIUS Business Overview
Table 75. SOTERIUS Pharmacovigilance Services Product
Table 76. SOTERIUS Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 77. SOTERIUS Recent Development
Table 78. SGS Company Detail
Table 79. SGS Business Overview
Table 80. SGS Pharmacovigilance Services Product
Table 81. SGS Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 82. SGS Recent Development
Table 83. Medpace Company Detail
Table 84. Medpace Business Overview
Table 85. Medpace Pharmacovigilance Services Product
Table 86. Medpace Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 87. Medpace Recent Development
Table 88. PPD Company Detail
Table 89. PPD Business Overview
Table 90. PPD Pharmacovigilance Services Product
Table 91. PPD Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 92. PPD Recent Development
Table 93. QVigilance Company Detail
Table 94. QVigilance Business Overview
Table 95. QVigilance Pharmacovigilance Services Product
Table 96. QVigilance Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 97. QVigilance Recent Development
Table 98. Freyr Solutions Company Detail
Table 99. Freyr Solutions Business Overview
Table 100. Freyr Solutions Pharmacovigilance Services Product
Table 101. Freyr Solutions Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 102. Freyr Solutions Recent Development
Table 103. Navitas Life Sciences Company Detail
Table 104. Navitas Life Sciences Business Overview
Table 105. Navitas Life Sciences Pharmacovigilance Services Product
Table 106. Navitas Life Sciences Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 107. Navitas Life Sciences Recent Development
Table 108. MMS Holdings Company Detail
Table 109. MMS Holdings Business Overview
Table 110. MMS Holdings Pharmacovigilance Services Product
Table 111. MMS Holdings Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 112. MMS Holdings Recent Development
Table 113. Amarex Company Detail
Table 114. Amarex Business Overview
Table 115. Amarex Pharmacovigilance Services Product
Table 116. Amarex Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 117. Amarex Recent Development
Table 118. Astrix Technology Group Company Detail
Table 119. Astrix Technology Group Business Overview
Table 120. Astrix Technology Group Pharmacovigilance Services Product
Table 121. Astrix Technology Group Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 122. Astrix Technology Group Recent Development
Table 123. Cambridge Regulatory Services Company Detail
Table 124. Cambridge Regulatory Services Business Overview
Table 125. Cambridge Regulatory Services Pharmacovigilance Services Product
Table 126. Cambridge Regulatory Services Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 127. Cambridge Regulatory Services Recent Development
Table 128. CROMSOURCE Company Detail
Table 129. CROMSOURCE Business Overview
Table 130. CROMSOURCE Pharmacovigilance Services Product
Table 131. CROMSOURCE Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 132. CROMSOURCE Recent Development
Table 133. APCER Life Sciences Company Detail
Table 134. APCER Life Sciences Business Overview
Table 135. APCER Life Sciences Pharmacovigilance Services Product
Table 136. APCER Life Sciences Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 137. APCER Life Sciences Recent Development
Table 138. Pharmya Company Detail
Table 139. Pharmya Business Overview
Table 140. Pharmya Pharmacovigilance Services Product
Table 141. Pharmya Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 142. Pharmya Recent Development
Table 143. A+Science Company Detail
Table 144. A+Science Business Overview
Table 145. A+Science Pharmacovigilance Services Product
Table 146. A+Science Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 147. A+Science Recent Development
Table 148. Midas Pharma Company Detail
Table 149. Midas Pharma Business Overview
Table 150. Midas Pharma Pharmacovigilance Services Product
Table 151. Midas Pharma Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 152. Midas Pharma Recent Development
Table 153. George Clinical Company Detail
Table 154. George Clinical Business Overview
Table 155. George Clinical Pharmacovigilance Services Product
Table 156. George Clinical Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 157. George Clinical Recent Development
Table 158. Syneos Health Company Detail
Table 159. Syneos Health Business Overview
Table 160. Syneos Health Pharmacovigilance Services Product
Table 161. Syneos Health Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 162. Syneos Health Recent Development
Table 163. INPHARMATIS Company Detail
Table 164. INPHARMATIS Business Overview
Table 165. INPHARMATIS Pharmacovigilance Services Product
Table 166. INPHARMATIS Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 167. INPHARMATIS Recent Development
Table 168. Taimei Technology Company Detail
Table 169. Taimei Technology Business Overview
Table 170. Taimei Technology Pharmacovigilance Services Product
Table 171. Taimei Technology Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 172. Taimei Technology Recent Development
Table 173. Extedo Company Detail
Table 174. Extedo Business Overview
Table 175. Extedo Pharmacovigilance Services Product
Table 176. Extedo Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 177. Extedo Recent Development
Table 178. WCG Clinical Company Detail
Table 179. WCG Clinical Business Overview
Table 180. WCG Clinical Pharmacovigilance Services Product
Table 181. WCG Clinical Revenue in Pharmacovigilance Services Business (2019-2024) & (US$ Million)
Table 182. WCG Clinical Recent Development
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmacovigilance Services Market Share by Type: 2023 VS 2030
Figure 3. Adverse Event Case Management Features
Figure 4. Aggregate Reporting Features
Figure 5. Signal Intelligence Features
Figure 6. Risk Management Features
Figure 7. Global Pharmacovigilance Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pharmacovigilance Services Market Share by Application: 2023 VS 2030
Figure 9. Biotechnology and Pharmaceuticals Case Studies
Figure 10. Contract Research Organization Case Studies
Figure 11. Hospital Case Studies
Figure 12. KPO / BPO Case Studies
Figure 13. Healthcare Institutions Case Studies
Figure 14. Others Case Studies
Figure 15. Pharmacovigilance Services Report Years Considered
Figure 16. Global Pharmacovigilance Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Pharmacovigilance Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Pharmacovigilance Services Market Share by Region: 2023 VS 2030
Figure 19. Global Pharmacovigilance Services Market Share by Players in 2023
Figure 20. Global Top Pharmacovigilance Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Services as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Pharmacovigilance Services Revenue in 2023
Figure 22. North America Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Pharmacovigilance Services Market Share by Country (2019-2030)
Figure 24. United States Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Pharmacovigilance Services Market Share by Country (2019-2030)
Figure 28. Germany Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Pharmacovigilance Services Market Share by Region (2019-2030)
Figure 36. China Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Pharmacovigilance Services Market Share by Country (2019-2030)
Figure 44. Mexico Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Pharmacovigilance Services Market Share by Country (2019-2030)
Figure 48. Turkey Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Pharmacovigilance Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. PrimeVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 51. Quanticate Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 52. ProPharma Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 53. Parexel Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 54. Accenture Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 55. SOTERIUS Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 56. SGS Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 57. Medpace Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 58. PPD Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 59. QVigilance Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 60. Freyr Solutions Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 61. Navitas Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 62. MMS Holdings Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 63. Amarex Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 64. Astrix Technology Group Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 65. Cambridge Regulatory Services Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 66. CROMSOURCE Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 67. APCER Life Sciences Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 68. Pharmya Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 69. A+Science Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 70. Midas Pharma Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 71. George Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 72. Syneos Health Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 73. INPHARMATIS Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 74. Taimei Technology Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 75. Extedo Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 76. WCG Clinical Revenue Growth Rate in Pharmacovigilance Services Business (2019-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}